Hims Appears in 89.7% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending ED Treatment Pills. For more detail, you can also read ED Treatment Pills: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Learn More
Key Takeaways
- Hims appears in nearly every benchmark answer and is recommended in about two-thirds, making it the strongest visible option in the category.
- The main risk is not reach but accuracy: several AI answers conflict on pricing, cash-pay comparisons, and per-dose sildenafil costs.
- Priority work starts with verifying the highest-impact claim, then updating owned pages and third-party citations only where evidence supports a correction.
- Buyer questions are mostly comparison-based, so future content should clearly answer how Hims compares with other telehealth and ED treatment providers.
Answer Capsule
In November 2026, Hims appeared in 252 of 281 AI answers included in the ED Treatment Pills benchmark (89.68%). It received 189 recommendations (67.26%), with 144 Top 3 placements and 75 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Hims mentions, recommendations and placements compare with its ED Treatment Pills peers?
Hims recorded 252 mentions (89.68%) and 189 recommendations (67.26%) across 281 answers included in the benchmark. Top 3 placements numbered 144; first-place recommendations numbered 75. Framing among its mentions was 192 positive, 57 neutral and 3 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Hims | 252 | 89.68% | 189 | 67.26% | 144 | 51.25% | 75 | 26.69% |
2 | Ro | 237 | 84.34% | 179 | 63.70% | 131 | 46.62% | 20 | 7.12% |
3 | 214 | 76.16% | 168 | 59.79% | 122 | 43.42% | 62 | 22.06% | |
4 | plushcare | 111 | 39.50% | 92 | 32.74% | 40 | 14.23% | 6 | 2.14% |
5 | Lemonaid Health | 98 | 34.88% | 79 | 28.11% | 28 | 9.96% | 1 | 0.36% |
6 | 68 | 24.20% | 33 | 11.74% | 16 | 5.69% | 2 | 0.71% | |
6 | Rex MD | 51 | 18.15% | 33 | 11.74% | 17 | 6.05% | 1 | 0.36% |
8 | 20 | 7.12% | 20 | 7.12% | 12 | 4.27% | 5 | 1.78% | |
9 | Optum | 22 | 7.83% | 17 | 6.05% | 14 | 4.98% | 7 | 2.49% |
10 | K Health | 17 | 6.05% | 15 | 5.34% | 5 | 1.78% | 1 | 0.36% |
Hims appears in nearly every benchmark answer and is endorsed in roughly two-thirds of them, which puts it ahead of the named competitors on both reach and recommendation. The gap is widest at the top of the list: Hims holds first place far more often than its closest rival, so it is not merely present but frequently the lead option.
That lead is an asset worth protecting rather than a result to celebrate. The agency would build a visibility scorecard that tracks reach, endorsement and top placement separately, so any erosion in the strongest position is caught early. Framing is largely positive, but positive wording alone is not endorsement, and the scorecard should keep those measures distinct.
What changed since last month
Questions This Section Answers
- How did Hims counts and coverage differ across the available monthly snapshots?
Metric | Oct 2026 | Nov 2026 |
|---|---|---|
Mentions | 274 / 296 (92.57%) | 252 / 281 (89.68%) |
Recommendations | 180 / 296 (60.81%) | 189 / 281 (67.26%) |
Top 3 recommendations | 144 / 296 (48.65%) | 144 / 281 (51.25%) |
#1 recommendations | 84 / 296 (28.38%) | 75 / 281 (26.69%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
From October 2026 to November 2026, Hims' mention count fell from 274 to 252, while its recommendation count rose from 180 to 189. The recommendation rate was 60.81% and 67.26% respectively.
Between the two selected months, Hims was mentioned less often but recommended more often, and its first-place count eased while its top-three count held steady. The movement is worth watching, but the two monthly samples are not directly comparable, so the shift should be read as an observation rather than a trend.
The agency would treat the next few months as a sequence of separate readings and look for a consistent direction before adjusting strategy. In the meantime, the recommendation gain is the more useful signal to protect, since endorsement is what turns a mention into a reason for a buyer to choose Hims.
AI recommendation trend
Observed recommendation rate (%), Oct 2026 to Nov 2026
- Hims+6.45 ppOct 202660.81%Nov 202667.26%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Hims?
AI answers contained 6 conflicting claims about Hims: 0 critical, 1 high, 5 medium, 0 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
The benchmark surfaced a small set of conflicting claims about Hims, and only one of them carries high priority. That single claim concerns cash-pay price competitiveness against a named rival, which is exactly the kind of comparison a prospective buyer may act on, so it deserves attention before the medium-priority items.
The agency would build a scoped fact-review register listing each disputed claim with an owner, the primary source needed to settle it and a review status. The register would rank the high-priority item first and treat the remaining topics as a queue, not a verdict on anyone's accuracy.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Hims should be verified before proposed page edits?
Review topic | Severity | Recorded AI claim A | Recorded AI claim B |
|---|---|---|---|
generic sildenafil monthly price | medium | ~$22/mo | ~$4/dose |
weight-loss program monthly cost | medium | $149–$299/month medication plus $39 first month then $149/month membership | $188–$298/month total after initial period |
cash-pay price competitiveness vs Ro | high | Ro is the better/cheaper deal overall for cash pay | Hims is cheaper for cash pay |
as-needed sildenafil price per dose | medium | ~$3.38 per dose | inexpensive / cheaper than BlueChew |
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
The disputed topics cluster around price: monthly medication cost, per-dose sildenafil pricing and how Hims compares with a rival on cash pay. Each pair of recorded claims could reflect different dates, package sizes or dosing assumptions rather than a genuine contradiction, so the entity and date must be pinned down before anything is called an error.
The agency would verify each topic against current primary sources and only then draft a conditional page brief. Where the evidence supports the existing wording, the brief records a no-change decision; where it does not, the brief specifies the correction and the source that justifies it.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Hims?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://innerbody.com/bluechew-vs-hims | 44 | 2 | 3 |
https://medicalnewstoday.com/articles/bluechew-vs-hims | 38 | 0 | 2 |
https://bluechew.com/blogs/medication/bluechew-vs-hims | 18 | 0 | 2 |
https://bluechew.com/blogs/medication/hims-reviews | 7 | 0 | 2 |
https://bluechew.com/sildenafil | 12 | 0 | 2 |
https://health.harvard.edu/mens-health/need-a-prescription-for-an-ed-medication-what-to-know-about-bluechew-hims-roman-and-other-online-ed-medication-retailers | 37 | 25 | 1 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
Several third-party pages were selected for review because they connect to Hims in the captured answers, and a few of them carry more than one disputed claim. Citation is not the same as influence, and a page linked to a conflicting claim is not necessarily its cause, so none of these pages should be treated as faulty on the strength of the link alone.
The agency would check the current contents of the shortlisted pages, starting with those tied to the high-priority price claim, and prepare evidence-backed requests only where a genuine inaccuracy is confirmed. Pages that turn out to be accurate would be logged as reviewed with no request sent.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Hims website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://hims.com/erectile-dysfunction/sildenafil | 56 | 33 | 26 |
https://hims.com/blog/hims-vs-bluechew | 38 | 0 | 0 |
https://hims.com/erectile-dysfunction | 38 | 17 | 16 |
https://hims.com/erectile-dysfunction/viagra | 35 | 19 | 17 |
https://hims.com/blog/is-cialis-over-the-counter | 20 | 7 | 6 |
https://hims.com/erectile-dysfunction/tadalafil | 16 | 6 | 5 |
https://hims.com/blog/how-get-viagra-where-buy-need-prescription | 15 | 3 | 3 |
https://hims.com/erectile-dysfunction/cialis | 14 | 12 | 10 |
The company's website was cited 436 times across 104 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
Hims' own site is cited widely, and the sildenafil page stands out as the page most often cited in answers that recommend the company. That makes it the natural first candidate for a page brief, with the broader erectile-dysfunction pages close behind. Some cited pages, including comparison blog posts, drew citations without appearing in recommending answers.
The agency would draft briefs that restate approved facts clearly, answer the buyer questions the page is meant to serve and remove ambiguity around pricing. Each brief would be checked against current page contents before any change is proposed, since a citation does not confirm what the page currently says.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Hims?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What are the top telemedicine companies? | 4 | 4 | 3 |
Who are the top telehealth providers? | 4 | 4 | 3 |
What are the best online ED pills? | 3 | 3 | 3 |
What is the best online prescription? | 3 | 3 | 3 |
What's the best ED medication online? | 3 | 3 | 3 |
What is the best online ED medication? | 3 | 3 | 2 |
What's the best ED treatment online? | 3 | 3 | 2 |
What is the best online healthcare? | 2 | 2 | 2 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions are mostly list-style comparisons asking for the best online ED medication or telehealth provider. Hims is mentioned in nearly all of them and recommended in most, so the opportunity is less about being absent and more about being the clear, well-evidenced choice when a buyer is comparing options.
The agency would check existing coverage before proposing anything new, then draft buyer-question content that answers the comparison directly with approved facts. These observations are recorded answers, not search volume, so the briefs should be framed around answering the question well rather than around assumed demand.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Hims work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline: a visibility scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and an evidence requirement. Nothing is corrected in this phase; the goal is a clean, reviewable record.
The second month turns verified findings into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses logged separately. The third month produces buyer-content briefs and a fresh scorecard. Completed work is recorded apart from measured answer outcomes, and no visibility gain is promised.
Methodology
Questions This Section Answers
- How are Hims answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 281 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5650 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Oct 2026 | 296 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Nov 2026 | 281 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison.
The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.
The monthly samples differ, and the exact collection dates of the original answers are unverified, so month-to-month movements show what was recorded, not why it changed. Recommendation requires both endorsement and positive wording, and top-three and first-place counts sit inside recommendations rather than adding to them.
Answers can mention several companies, so company counts cannot be summed into a total number of answers. Sentiment describes answer wording, not customer satisfaction. Cited pages and disputed claims still need independent verification before any correction is proposed.
Our first three priorities
First, settle the high-priority cash-pay price claim against current primary sources, since it is the one disputed point most likely to shape a buyer's comparison. The agency would confirm the entity, date and package assumptions before deciding whether a correction is warranted, and log the outcome either way.
Second, prepare a page brief for the sildenafil page, the most-cited owned page in recommending answers, restating approved pricing and dosing facts plainly. Third, draft buyer-question content for the list-style comparison questions where Hims already appears, checking existing coverage first. Each step is proposed work, not a measured result.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.
What Is AI Citation Intelligence?
What Is Citation Architecture?
What Is Generative Engine Optimization?
What Is AI Share of Voice?
Archived editions
Browse earlier published research snapshots for this article. The latest edition remains at the current URL.


